Global Genetically Engineered Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Genetically Engineered Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Genetically Engineered Vaccines players cover Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Sanofi, Zoties and Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Genetically Engineered Vaccines Industry Forecast” looks at past sales and reviews total world Genetically Engineered Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Genetically Engineered Vaccines sales for 2023 through 2029. With Genetically Engineered Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Engineered Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Genetically Engineered Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Engineered Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Genetically Engineered Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Engineered Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Engineered Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Engineered Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Genetically Engineered Vaccines market?
What factors are driving Genetically Engineered Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genetically Engineered Vaccines market opportunities vary by end market size?
How does Genetically Engineered Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Genetically Engineered Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Genetically Engineered Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Genetically Engineered Vaccines players cover Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Sanofi, Zoties and Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Genetically Engineered Vaccines Industry Forecast” looks at past sales and reviews total world Genetically Engineered Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Genetically Engineered Vaccines sales for 2023 through 2029. With Genetically Engineered Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Engineered Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Genetically Engineered Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Engineered Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Genetically Engineered Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Engineered Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Engineered Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Engineered Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Veterinary Use
- Human Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Merck
- GSK
- Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
- Walvax Biotechnology Co., Ltd.
- Bharat Biotech
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Sant? Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
What is the 10-year outlook for the global Genetically Engineered Vaccines market?
What factors are driving Genetically Engineered Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genetically Engineered Vaccines market opportunities vary by end market size?
How does Genetically Engineered Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Engineered Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Genetically Engineered Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Genetically Engineered Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Genetically Engineered Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.3 Genetically Engineered Vaccines Sales by Type
2.3.1 Global Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Genetically Engineered Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Genetically Engineered Vaccines Sale Price by Type (2018-2023)
2.4 Genetically Engineered Vaccines Segment by Application
2.4.1 Veterinary Use
2.4.2 Human Use
2.5 Genetically Engineered Vaccines Sales by Application
2.5.1 Global Genetically Engineered Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Genetically Engineered Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Genetically Engineered Vaccines Sale Price by Application (2018-2023)
3 GLOBAL GENETICALLY ENGINEERED VACCINES BY COMPANY
3.1 Global Genetically Engineered Vaccines Breakdown Data by Company
3.1.1 Global Genetically Engineered Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Genetically Engineered Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Genetically Engineered Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Genetically Engineered Vaccines Revenue by Company (2018-2023)
3.2.2 Global Genetically Engineered Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Genetically Engineered Vaccines Sale Price by Company
3.4 Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Engineered Vaccines Product Location Distribution
3.4.2 Players Genetically Engineered Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Genetically Engineered Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Genetically Engineered Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Genetically Engineered Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Genetically Engineered Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Genetically Engineered Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Genetically Engineered Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Genetically Engineered Vaccines Sales Growth
4.4 APAC Genetically Engineered Vaccines Sales Growth
4.5 Europe Genetically Engineered Vaccines Sales Growth
4.6 Middle East & Africa Genetically Engineered Vaccines Sales Growth
5 AMERICAS
5.1 Americas Genetically Engineered Vaccines Sales by Country
5.1.1 Americas Genetically Engineered Vaccines Sales by Country (2018-2023)
5.1.2 Americas Genetically Engineered Vaccines Revenue by Country (2018-2023)
5.2 Americas Genetically Engineered Vaccines Sales by Type
5.3 Americas Genetically Engineered Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Engineered Vaccines Sales by Region
6.1.1 APAC Genetically Engineered Vaccines Sales by Region (2018-2023)
6.1.2 APAC Genetically Engineered Vaccines Revenue by Region (2018-2023)
6.2 APAC Genetically Engineered Vaccines Sales by Type
6.3 APAC Genetically Engineered Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Engineered Vaccines by Country
7.1.1 Europe Genetically Engineered Vaccines Sales by Country (2018-2023)
7.1.2 Europe Genetically Engineered Vaccines Revenue by Country (2018-2023)
7.2 Europe Genetically Engineered Vaccines Sales by Type
7.3 Europe Genetically Engineered Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Engineered Vaccines by Country
8.1.1 Middle East & Africa Genetically Engineered Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Genetically Engineered Vaccines Sales by Type
8.3 Middle East & Africa Genetically Engineered Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines
10.3 Manufacturing Process Analysis of Genetically Engineered Vaccines
10.4 Industry Chain Structure of Genetically Engineered Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Engineered Vaccines Distributors
11.3 Genetically Engineered Vaccines Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
12.1 Global Genetically Engineered Vaccines Market Size Forecast by Region
12.1.1 Global Genetically Engineered Vaccines Forecast by Region (2024-2029)
12.1.2 Global Genetically Engineered Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetically Engineered Vaccines Forecast by Type
12.7 Global Genetically Engineered Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
13.1.3 Pfizer Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Genetically Engineered Vaccines Product Portfolios and Specifications
13.2.3 Merck Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Genetically Engineered Vaccines Product Portfolios and Specifications
13.3.3 GSK Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
13.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
13.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
13.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business Overview
13.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
13.5 Walvax Biotechnology Co., Ltd.
13.5.1 Walvax Biotechnology Co., Ltd. Company Information
13.5.2 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Walvax Biotechnology Co., Ltd. Main Business Overview
13.5.5 Walvax Biotechnology Co., Ltd. Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
13.7.3 Sanofi Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Zoties
13.8.1 Zoties Company Information
13.8.2 Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
13.8.3 Zoties Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zoties Main Business Overview
13.8.5 Zoties Latest Developments
13.9 Elanco
13.9.1 Elanco Company Information
13.9.2 Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
13.9.3 Elanco Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Elanco Main Business Overview
13.9.5 Elanco Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
13.11.3 Indian Immunologicals Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
13.12 China Animal Husbandry Industry Co.,Ltd.
13.12.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.12.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.12.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.13 Yebio Bioengineering Co., Ltd Of Qingdao
13.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
13.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.14 Jinyu Bio-technology Co.,ltd.
13.14.1 Jinyu Bio-technology Co.,ltd. Company Information
13.14.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.14.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.15 HVRI
13.15.1 HVRI Company Information
13.15.2 HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
13.15.3 HVRI Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 HVRI Main Business Overview
13.15.5 HVRI Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
13.16.3 Ringpu Biology Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Kyoto Biken Laboratories
13.17.1 Kyoto Biken Laboratories Company Information
13.17.2 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
13.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Kyoto Biken Laboratories Main Business Overview
13.17.5 Kyoto Biken Laboratories Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
13.18.3 FATRO Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Pulike Biological Engineering,Inc.
13.20.1 Pulike Biological Engineering,Inc. Company Information
13.20.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
13.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Pulike Biological Engineering,Inc. Main Business Overview
13.20.5 Pulike Biological Engineering,Inc. Latest Developments
13.21 Wuhan Hvsen Biotechnology CO.,LTD
13.21.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.21.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
13.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.21.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.22 Jinhe Biotechnology Co., Ltd.
13.22.1 Jinhe Biotechnology Co., Ltd. Company Information
13.22.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.22.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.23 Shanghai Shen Lian Biomedical Corporation
13.23.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.23.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
13.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.23.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.24 Qingdao Vland Biotech INC.
13.24.1 Qingdao Vland Biotech INC. Company Information
13.24.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
13.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Qingdao Vland Biotech INC. Main Business Overview
13.24.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Engineered Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Genetically Engineered Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Genetically Engineered Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Genetically Engineered Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.3 Genetically Engineered Vaccines Sales by Type
2.3.1 Global Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Genetically Engineered Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Genetically Engineered Vaccines Sale Price by Type (2018-2023)
2.4 Genetically Engineered Vaccines Segment by Application
2.4.1 Veterinary Use
2.4.2 Human Use
2.5 Genetically Engineered Vaccines Sales by Application
2.5.1 Global Genetically Engineered Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Genetically Engineered Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Genetically Engineered Vaccines Sale Price by Application (2018-2023)
3 GLOBAL GENETICALLY ENGINEERED VACCINES BY COMPANY
3.1 Global Genetically Engineered Vaccines Breakdown Data by Company
3.1.1 Global Genetically Engineered Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Genetically Engineered Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Genetically Engineered Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Genetically Engineered Vaccines Revenue by Company (2018-2023)
3.2.2 Global Genetically Engineered Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Genetically Engineered Vaccines Sale Price by Company
3.4 Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Engineered Vaccines Product Location Distribution
3.4.2 Players Genetically Engineered Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Genetically Engineered Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Genetically Engineered Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Genetically Engineered Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Genetically Engineered Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Genetically Engineered Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Genetically Engineered Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Genetically Engineered Vaccines Sales Growth
4.4 APAC Genetically Engineered Vaccines Sales Growth
4.5 Europe Genetically Engineered Vaccines Sales Growth
4.6 Middle East & Africa Genetically Engineered Vaccines Sales Growth
5 AMERICAS
5.1 Americas Genetically Engineered Vaccines Sales by Country
5.1.1 Americas Genetically Engineered Vaccines Sales by Country (2018-2023)
5.1.2 Americas Genetically Engineered Vaccines Revenue by Country (2018-2023)
5.2 Americas Genetically Engineered Vaccines Sales by Type
5.3 Americas Genetically Engineered Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Engineered Vaccines Sales by Region
6.1.1 APAC Genetically Engineered Vaccines Sales by Region (2018-2023)
6.1.2 APAC Genetically Engineered Vaccines Revenue by Region (2018-2023)
6.2 APAC Genetically Engineered Vaccines Sales by Type
6.3 APAC Genetically Engineered Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Engineered Vaccines by Country
7.1.1 Europe Genetically Engineered Vaccines Sales by Country (2018-2023)
7.1.2 Europe Genetically Engineered Vaccines Revenue by Country (2018-2023)
7.2 Europe Genetically Engineered Vaccines Sales by Type
7.3 Europe Genetically Engineered Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Engineered Vaccines by Country
8.1.1 Middle East & Africa Genetically Engineered Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Genetically Engineered Vaccines Sales by Type
8.3 Middle East & Africa Genetically Engineered Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines
10.3 Manufacturing Process Analysis of Genetically Engineered Vaccines
10.4 Industry Chain Structure of Genetically Engineered Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Engineered Vaccines Distributors
11.3 Genetically Engineered Vaccines Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
12.1 Global Genetically Engineered Vaccines Market Size Forecast by Region
12.1.1 Global Genetically Engineered Vaccines Forecast by Region (2024-2029)
12.1.2 Global Genetically Engineered Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetically Engineered Vaccines Forecast by Type
12.7 Global Genetically Engineered Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
13.1.3 Pfizer Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Genetically Engineered Vaccines Product Portfolios and Specifications
13.2.3 Merck Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Genetically Engineered Vaccines Product Portfolios and Specifications
13.3.3 GSK Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
13.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
13.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
13.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business Overview
13.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
13.5 Walvax Biotechnology Co., Ltd.
13.5.1 Walvax Biotechnology Co., Ltd. Company Information
13.5.2 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Walvax Biotechnology Co., Ltd. Main Business Overview
13.5.5 Walvax Biotechnology Co., Ltd. Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
13.7.3 Sanofi Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Zoties
13.8.1 Zoties Company Information
13.8.2 Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
13.8.3 Zoties Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zoties Main Business Overview
13.8.5 Zoties Latest Developments
13.9 Elanco
13.9.1 Elanco Company Information
13.9.2 Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
13.9.3 Elanco Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Elanco Main Business Overview
13.9.5 Elanco Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
13.11.3 Indian Immunologicals Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
13.12 China Animal Husbandry Industry Co.,Ltd.
13.12.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.12.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.12.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.13 Yebio Bioengineering Co., Ltd Of Qingdao
13.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
13.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.14 Jinyu Bio-technology Co.,ltd.
13.14.1 Jinyu Bio-technology Co.,ltd. Company Information
13.14.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.14.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.15 HVRI
13.15.1 HVRI Company Information
13.15.2 HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
13.15.3 HVRI Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 HVRI Main Business Overview
13.15.5 HVRI Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
13.16.3 Ringpu Biology Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Kyoto Biken Laboratories
13.17.1 Kyoto Biken Laboratories Company Information
13.17.2 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
13.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Kyoto Biken Laboratories Main Business Overview
13.17.5 Kyoto Biken Laboratories Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
13.18.3 FATRO Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Pulike Biological Engineering,Inc.
13.20.1 Pulike Biological Engineering,Inc. Company Information
13.20.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
13.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Pulike Biological Engineering,Inc. Main Business Overview
13.20.5 Pulike Biological Engineering,Inc. Latest Developments
13.21 Wuhan Hvsen Biotechnology CO.,LTD
13.21.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.21.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
13.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.21.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.22 Jinhe Biotechnology Co., Ltd.
13.22.1 Jinhe Biotechnology Co., Ltd. Company Information
13.22.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.22.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.23 Shanghai Shen Lian Biomedical Corporation
13.23.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.23.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
13.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.23.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.24 Qingdao Vland Biotech INC.
13.24.1 Qingdao Vland Biotech INC. Company Information
13.24.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
13.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Qingdao Vland Biotech INC. Main Business Overview
13.24.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetically Engineered Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Genetically Engineered Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Genetically Engineered Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Genetically Engineered Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Genetically Engineered Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Genetically Engineered Vaccines Revenue by Application (2018-2023)
Table 14. Global Genetically Engineered Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Genetically Engineered Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Genetically Engineered Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Genetically Engineered Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Genetically Engineered Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Genetically Engineered Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Genetically Engineered Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution and Sales Area
Table 22. Players Genetically Engineered Vaccines Products Offered
Table 23. Genetically Engineered Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Genetically Engineered Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Genetically Engineered Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Genetically Engineered Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Genetically Engineered Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Genetically Engineered Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Genetically Engineered Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Genetically Engineered Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Genetically Engineered Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Genetically Engineered Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Genetically Engineered Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Genetically Engineered Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Genetically Engineered Vaccines
Table 59. Key Market Challenges & Risks of Genetically Engineered Vaccines
Table 60. Key Industry Trends of Genetically Engineered Vaccines
Table 61. Genetically Engineered Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Genetically Engineered Vaccines Distributors List
Table 64. Genetically Engineered Vaccines Customer List
Table 65. Global Genetically Engineered Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Genetically Engineered Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Genetically Engineered Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Genetically Engineered Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Genetically Engineered Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Genetically Engineered Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Genetically Engineered Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Genetically Engineered Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
Table 81. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Merck Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Genetically Engineered Vaccines Product Portfolios and Specifications
Table 86. Merck Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. GSK Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. GSK Genetically Engineered Vaccines Product Portfolios and Specifications
Table 91. GSK Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. GSK Main Business
Table 93. GSK Latest Developments
Table 94. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 96. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business
Table 98. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
Table 99. Walvax Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 101. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Walvax Biotechnology Co., Ltd. Main Business
Table 103. Walvax Biotechnology Co., Ltd. Latest Developments
Table 104. Bharat Biotech Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
Table 106. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bharat Biotech Main Business
Table 108. Bharat Biotech Latest Developments
Table 109. Sanofi Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
Table 111. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
Table 114. Zoties Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
Table 116. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Zoties Main Business
Table 118. Zoties Latest Developments
Table 119. Elanco Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
Table 121. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Elanco Main Business
Table 123. Elanco Latest Developments
Table 124. Boehringer Ingelheim Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
Table 126. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Boehringer Ingelheim Main Business
Table 128. Boehringer Ingelheim Latest Developments
Table 129. Indian Immunologicals Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
Table 131. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Indian Immunologicals Main Business
Table 133. Indian Immunologicals Latest Developments
Table 134. China Animal Husbandry Industry Co.,Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 136. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 138. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 139. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
Table 141. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 143. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 144. Jinyu Bio-technology Co.,ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 146. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Jinyu Bio-technology Co.,ltd. Main Business
Table 148. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 149. HVRI Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
Table 151. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. HVRI Main Business
Table 153. HVRI Latest Developments
Table 154. Ringpu Biology Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
Table 156. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Ringpu Biology Main Business
Table 158. Ringpu Biology Latest Developments
Table 159. Kyoto Biken Laboratories Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 160. Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
Table 161. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Kyoto Biken Laboratories Main Business
Table 163. Kyoto Biken Laboratories Latest Developments
Table 164. FATRO Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 165. FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
Table 166. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. FATRO Main Business
Table 168. FATRO Latest Developments
Table 169. Ceva Sant? Animale Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 170. Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
Table 171. Ceva Sant? Animale Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Ceva Sant? Animale Main Business
Table 173. Ceva Sant? Animale Latest Developments
Table 174. Pulike Biological Engineering,Inc. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 175. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 176. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Pulike Biological Engineering,Inc. Main Business
Table 178. Pulike Biological Engineering,Inc. Latest Developments
Table 179. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 180. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
Table 181. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 182. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 183. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 184. Jinhe Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 185. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 186. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 187. Jinhe Biotechnology Co., Ltd. Main Business
Table 188. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 189. Shanghai Shen Lian Biomedical Corporation Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 190. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
Table 191. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 192. Shanghai Shen Lian Biomedical Corporation Main Business
Table 193. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 194. Qingdao Vland Biotech INC. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 195. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 196. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 197. Qingdao Vland Biotech INC. Main Business
Table 198. Qingdao Vland Biotech INC. Latest Developments
Table 1. Genetically Engineered Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Genetically Engineered Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Genetically Engineered Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Genetically Engineered Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Genetically Engineered Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Genetically Engineered Vaccines Revenue by Application (2018-2023)
Table 14. Global Genetically Engineered Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Genetically Engineered Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Genetically Engineered Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Genetically Engineered Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Genetically Engineered Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Genetically Engineered Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Genetically Engineered Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution and Sales Area
Table 22. Players Genetically Engineered Vaccines Products Offered
Table 23. Genetically Engineered Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Genetically Engineered Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Genetically Engineered Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Genetically Engineered Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Genetically Engineered Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Genetically Engineered Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Genetically Engineered Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Genetically Engineered Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Genetically Engineered Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Genetically Engineered Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Genetically Engineered Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Genetically Engineered Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Genetically Engineered Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Genetically Engineered Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Genetically Engineered Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Genetically Engineered Vaccines
Table 59. Key Market Challenges & Risks of Genetically Engineered Vaccines
Table 60. Key Industry Trends of Genetically Engineered Vaccines
Table 61. Genetically Engineered Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Genetically Engineered Vaccines Distributors List
Table 64. Genetically Engineered Vaccines Customer List
Table 65. Global Genetically Engineered Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Genetically Engineered Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Genetically Engineered Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Genetically Engineered Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Genetically Engineered Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Genetically Engineered Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Genetically Engineered Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Genetically Engineered Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Genetically Engineered Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Genetically Engineered Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
Table 81. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Merck Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Genetically Engineered Vaccines Product Portfolios and Specifications
Table 86. Merck Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. GSK Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. GSK Genetically Engineered Vaccines Product Portfolios and Specifications
Table 91. GSK Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. GSK Main Business
Table 93. GSK Latest Developments
Table 94. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 96. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business
Table 98. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
Table 99. Walvax Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 101. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Walvax Biotechnology Co., Ltd. Main Business
Table 103. Walvax Biotechnology Co., Ltd. Latest Developments
Table 104. Bharat Biotech Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
Table 106. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bharat Biotech Main Business
Table 108. Bharat Biotech Latest Developments
Table 109. Sanofi Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
Table 111. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
Table 114. Zoties Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
Table 116. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Zoties Main Business
Table 118. Zoties Latest Developments
Table 119. Elanco Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
Table 121. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Elanco Main Business
Table 123. Elanco Latest Developments
Table 124. Boehringer Ingelheim Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
Table 126. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Boehringer Ingelheim Main Business
Table 128. Boehringer Ingelheim Latest Developments
Table 129. Indian Immunologicals Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
Table 131. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Indian Immunologicals Main Business
Table 133. Indian Immunologicals Latest Developments
Table 134. China Animal Husbandry Industry Co.,Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 136. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 138. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 139. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
Table 141. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 143. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 144. Jinyu Bio-technology Co.,ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 146. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Jinyu Bio-technology Co.,ltd. Main Business
Table 148. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 149. HVRI Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
Table 151. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. HVRI Main Business
Table 153. HVRI Latest Developments
Table 154. Ringpu Biology Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
Table 156. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Ringpu Biology Main Business
Table 158. Ringpu Biology Latest Developments
Table 159. Kyoto Biken Laboratories Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 160. Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
Table 161. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Kyoto Biken Laboratories Main Business
Table 163. Kyoto Biken Laboratories Latest Developments
Table 164. FATRO Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 165. FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
Table 166. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. FATRO Main Business
Table 168. FATRO Latest Developments
Table 169. Ceva Sant? Animale Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 170. Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
Table 171. Ceva Sant? Animale Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Ceva Sant? Animale Main Business
Table 173. Ceva Sant? Animale Latest Developments
Table 174. Pulike Biological Engineering,Inc. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 175. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 176. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Pulike Biological Engineering,Inc. Main Business
Table 178. Pulike Biological Engineering,Inc. Latest Developments
Table 179. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 180. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
Table 181. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 182. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 183. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 184. Jinhe Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 185. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 186. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 187. Jinhe Biotechnology Co., Ltd. Main Business
Table 188. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 189. Shanghai Shen Lian Biomedical Corporation Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 190. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
Table 191. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 192. Shanghai Shen Lian Biomedical Corporation Main Business
Table 193. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 194. Qingdao Vland Biotech INC. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 195. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 196. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 197. Qingdao Vland Biotech INC. Main Business
Table 198. Qingdao Vland Biotech INC. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Genetically Engineered Vaccines
Figure 2. Genetically Engineered Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Engineered Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Genetically Engineered Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Genetically Engineered Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Genetic Recombinant Vaccine
Figure 10. Product Picture of Recombinant Subunit Vaccines
Figure 11. Product Picture of Genetic Vaccine
Figure 12. Global Genetically Engineered Vaccines Sales Market Share by Type in 2022
Figure 13. Global Genetically Engineered Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Genetically Engineered Vaccines Consumed in Veterinary Use
Figure 15. Global Genetically Engineered Vaccines Market: Veterinary Use (2018-2023) & (K Units)
Figure 16. Genetically Engineered Vaccines Consumed in Human Use
Figure 17. Global Genetically Engineered Vaccines Market: Human Use (2018-2023) & (K Units)
Figure 18. Global Genetically Engineered Vaccines Sales Market Share by Application (2022)
Figure 19. Global Genetically Engineered Vaccines Revenue Market Share by Application in 2022
Figure 20. Genetically Engineered Vaccines Sales Market by Company in 2022 (K Units)
Figure 21. Global Genetically Engineered Vaccines Sales Market Share by Company in 2022
Figure 22. Genetically Engineered Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Genetically Engineered Vaccines Revenue Market Share by Company in 2022
Figure 24. Global Genetically Engineered Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 27. Americas Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 28. APAC Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 29. APAC Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. Europe Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 31. Europe Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Americas Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 35. Americas Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 36. Americas Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 37. Americas Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 38. United States Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Genetically Engineered Vaccines Sales Market Share by Region in 2022
Figure 43. APAC Genetically Engineered Vaccines Revenue Market Share by Regions in 2022
Figure 44. APAC Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 45. APAC Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 46. China Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 54. Europe Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 55. Europe Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 56. Europe Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 57. Germany Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 66. Egypt Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines in 2022
Figure 72. Manufacturing Process Analysis of Genetically Engineered Vaccines
Figure 73. Industry Chain Structure of Genetically Engineered Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Genetically Engineered Vaccines Sales Market Forecast by Region (2024-2029)
Figure 76. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Genetically Engineered Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Genetically Engineered Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Genetically Engineered Vaccines
Figure 2. Genetically Engineered Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Engineered Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Genetically Engineered Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Genetically Engineered Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Genetic Recombinant Vaccine
Figure 10. Product Picture of Recombinant Subunit Vaccines
Figure 11. Product Picture of Genetic Vaccine
Figure 12. Global Genetically Engineered Vaccines Sales Market Share by Type in 2022
Figure 13. Global Genetically Engineered Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Genetically Engineered Vaccines Consumed in Veterinary Use
Figure 15. Global Genetically Engineered Vaccines Market: Veterinary Use (2018-2023) & (K Units)
Figure 16. Genetically Engineered Vaccines Consumed in Human Use
Figure 17. Global Genetically Engineered Vaccines Market: Human Use (2018-2023) & (K Units)
Figure 18. Global Genetically Engineered Vaccines Sales Market Share by Application (2022)
Figure 19. Global Genetically Engineered Vaccines Revenue Market Share by Application in 2022
Figure 20. Genetically Engineered Vaccines Sales Market by Company in 2022 (K Units)
Figure 21. Global Genetically Engineered Vaccines Sales Market Share by Company in 2022
Figure 22. Genetically Engineered Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Genetically Engineered Vaccines Revenue Market Share by Company in 2022
Figure 24. Global Genetically Engineered Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 27. Americas Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 28. APAC Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 29. APAC Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. Europe Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 31. Europe Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Genetically Engineered Vaccines Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Genetically Engineered Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Americas Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 35. Americas Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 36. Americas Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 37. Americas Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 38. United States Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Genetically Engineered Vaccines Sales Market Share by Region in 2022
Figure 43. APAC Genetically Engineered Vaccines Revenue Market Share by Regions in 2022
Figure 44. APAC Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 45. APAC Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 46. China Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 54. Europe Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 55. Europe Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 56. Europe Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 57. Germany Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Application (2018-2023)
Figure 66. Egypt Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Genetically Engineered Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines in 2022
Figure 72. Manufacturing Process Analysis of Genetically Engineered Vaccines
Figure 73. Industry Chain Structure of Genetically Engineered Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Genetically Engineered Vaccines Sales Market Forecast by Region (2024-2029)
Figure 76. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Genetically Engineered Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Genetically Engineered Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Application (2024-2029)
